Clovis Oncology, Inc. CLVS
Day range unavailable
52-week range unavailable
Discussion (3636)
Sign in to join the discussion
Going’s to green ?
Clovis Oncology (NASDAQ:CLVS) to Post FY2024 Earnings of ($0.04) Per Share, Piper Sandler Forecasts
Posted by Clara Ruiz on Jan 9th, 2020
Clovis Oncology logo
Clovis Oncology (NASDAQ:CLVS) – Equities researchers at Piper Sandler issued their FY2024 earnings per share estimates for Clovis Oncology in a research note issued on Tuesday, January 7th. Piper Sandler analyst J. Catanzaro forecasts that the biopharmaceutical company will post earnings of ($0.04) per share for the year.
Tk’s MAR$9. For News.
It's coming the best!! The plate. The good news of the Aprobación SNDA. + jp Morgan conference - MONDAY + Revenues And EPS. Projection $26. believe it!! Enjoy
$SMART.... You are “The Best”. The Best is COMING. Really....
I support you!!!
$MART$9X.
Projection $22 or 23. Soon.
I Don’t understand!!! What’s going on this Share. ???
This action is a fake and has the full potential to climb up to a good price.
A full potential!!! And he doesn't get up. Shit